XBI icon

SPDR S&P Biotech ETF

731 hedge funds and large institutions have $9.85B invested in SPDR S&P Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 193 increasing their positions, 280 reducing their positions, and 115 closing their positions.

Holders
731
Holders Change
-32
Holders Change %
-4.19%
% of All Funds
9.74%
Holding in Top 10
16
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-23.81%
% of All Funds
0.21%
New
101
Increased
193
Reduced
280
Closed
115
Calls
$2.07B
Puts
$3.32B
Net Calls
-$1.26B
Net Calls Change
-$729M
Name Market Value Shares Shares
Change
Shares
Change %
AGP
851
Artia Global Partners
Florida
XS
852
XR Securities
Illinois
SB
853
SIG Brokerage
New York
UOC
854
UBS O'Connor
Illinois
Walleye Trading
855
Walleye Trading
New York
CM
856
Caption Management
Oklahoma
FIA
857
FNY Investment Advisers
New York
CC
858
Centiva Capital
New York
DP
859
Diadema Partners
New Jersey
VCIM
860
Velan Capital Investment Management
Georgia
NM
861
NWI Management
New York
NMC
862
Nine Masts Capital
Hong Kong
Capital Fund Management (CFM)
863
Capital Fund Management (CFM)
France
ORAM
864
One River Asset Management
Connecticut
Hudson Bay Capital Management
865
Hudson Bay Capital Management
Connecticut
Nomura Holdings
866
Nomura Holdings
Japan
CM
867
Capula Management
Cayman Islands
PVI
868
Pura Vida Investments
New York
AAA
869
Affinity Asset Advisors
New York
ACM
870
AIGH Capital Management
Maryland
HT
871
HAP Trading
New York
SCM
872
Soleus Capital Management
Connecticut
PAMP
873
Polar Asset Management Partners
Ontario, Canada
IC
874
Ikarian Capital
Texas
GF
875
Greenhouse Funds
Maryland